. 2014 Sep-Oct;18(5):617–623. doi: 10.4103/2230-8210.139214
Copyright: © Indian Journal of Endocrinology and Metabolism
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 10.
SUs versus SGLT-2 inhibitors
